CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 21 enrolled
Drug / intervention
PET-cCTA-cFFRother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05349084
NCT05349084N/ACompleted
CompareCT.gov

PET MYOCARDIAL Blood Flow Comparison to Coronary CTA and CT-FFR

Washington University School of Medicine·interventional·Posted Apr 27, 2022·Updated Sep 26, 2024

In Brief

A clinical study evaluating PET-cCTA-cFFR for Coronary Artery Disease. Completed, enrolled 21 participants across 1 site.

Detailed Summary

The broad, long-term objective of this pilot study is to develop an optimal, clinically usable, non-invasive evaluation of Coronary Artery Disease (CAD) in the setting of stable angina which provides both anatomic and functional information. Patients already scheduled to undergo Invasive coronary catheterization (ICA) for the clinical indication of angina will be recruited to under go stress-rest Positron Emission Tomography-Coronary CT Angiography-Fractional Flow Reserve (PET-cCTA-cFFR)

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Artery Disease
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedApr 27, 2022
Enrollment StartJun 6, 2019
Primary CompletionJul 18, 2023
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 4.2 years ago

Interventions

PET-cCTA-cFFRother

patients presenting with stable angina and a moderate pretest likelihood for CAD who are already scheduled to undergo ICA for the clinical indication of angina will be recruited to undergo PET-cCTA-cFFR